Rifampicin at High Dose for Difficult-to-Treat Tuberculosis
Clinical trial NCT04768231 · UNKNOWN
Trial details
- NCT number
- NCT04768231
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-12-31
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.